For more than two decades, Dr. Ross Camidge has been a leading voice in lung cancer research. Now, the internationally ...

FirstHealth is inviting the community to take flight with them on Nov. 8 for the inaugural Wings of Hope Walk & Run. Taking ...

The United Hospital Center held its 7th annual Pro-Am golf tournament on Monday, with the proceeds benefitting the hospital’s ...

Researchers at the University of Oslo and Oslo University Hospital have developed a promising new immunotherapy targeting the ...

Lung cancer remains one of the deadliest cancers worldwide, with survival rates stubbornly low despite advances in surgery, ...

Novocure (NASDAQ: NVCR) announced that final results from the Phase 3 METIS trial of Tumor Treating Fields (TTFields) therapy for brain metastases from non-small cell lung cancer (NSCLC) will be ...

In this episode of the Treating Together podcast, Edward S. Kim, MD, MBA, and Neel Shah, MD, discuss the rapid advancements in lung cancer therapy, the challenges community physicians face in staying ...

Select your location to view local American Lung Association events and news near you.

Patients with lung cancer treated with immune checkpoint inhibitors are at significantly higher risk for certain major cardiovascular adverse events. Patients with lung cancer treated with immune ...

As lung cancer treatments evolve and more data are published, there is a need for updated recommendations on how to manage ...

Ibtrozi may become the new standard for ROS1-mutated lung cancer, with phase 2 data showing safer, longer-lasting benefits ...

Lung cancer screening guidelines do not exist for individuals who never smoked, but data presented at International ...